课题基金 / 基金详情

Studies on cancer genomics to develop personalized therapy and medicine in breast cancer: Whole exome sequencing analysis of primary breast cancer and its metastatic tumor.

Studies on cancer genomics to develop personalized therapy and medicine in breast cancer: Whole exome sequencing analysis of primary breast cancer and its metastatic tumor.
研究癌症基因组学以开发乳腺癌的个性化治疗和药物:原发性乳腺癌及其转移肿瘤的全外显子组测序分析。
批准号:
22310123
负责人:
HOSODA Fumie
金额:
$10.98万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2010
资助国家:
日本
项目状态:
已结题
起止时间:
2010 至 2012

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
转移是癌症患者治疗失败和死亡的主要原因。在原发乳腺肿瘤中已经发现了许多基因改变,但转移性肿瘤特有的基因改变还没有得到很好的研究。为了研究转移过程中发生的关键基因变化,我们用大规模平行测序的方法对14个三个样本进行了完整的外显子组测序:乳腺癌、其转移的淋巴结肿瘤和来自同一患者的配对的非癌组织。比较这三个基因组,我们发现了各种各样的体细胞变异,在原发肿瘤中有26-676(中位数=46)突变,在转移性淋巴结肿瘤中有8-1034(中位数37)突变。个体患者突变率的差异(最低34个单核苷酸变异(SNV),最高1710个SNV)表明,肿瘤发展的不同过程和不同的选择压力存在于肿瘤环境中。我们分别确定了132个和189个针对原发肿瘤和淋巴结肿瘤的复发突变,并用统计排名方法评估了它们的意义。我们的发现将为乳腺肿瘤转移的机制以及未来的个性化治疗和分子医学提供新的见解。
英文摘要
Metastasis is the main cause of therapeutic failure and death in cancer patients. A number of genetic alterations have been identified in primary breast tumors, but genetic changes particular to the metastatic tumors have not been well studied. To investigate critical genetic changes that occur during the metastatic process, we performed whole exome sequencing of 14 trio-specimens: the primary breast cancer, its metastatic lymph node tumor and matched non-cancerous tissue from the same patient by massively parallel sequencing. Comparing the three genomes, we identified a wide variety of somatic variations, 26-676 (median=46) mutations in the primary tumors and 8-1034 (median=37) mutations in the metastatic lymph node tumors. The differences of mutation rates (34 single nucleotide variations (SNVs) at the lowest to 1710 SNVs at the highest) in individual patients suggested that various processes of tumor development and distinct selective pressures are present within the tumor environment. We identified 132 and 189 recurrent mutations specific to the primary and lymph node tumors, respectively, and evaluated its significance with a statistical ranking method. Our findings will provide new insights for the mechanism of breast tumor metastasis and future personalized therapy and molecular medicine.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
DOI: 10.1371/journal.pone.0056010
发表时间: 2013
期刊: PloS one
影响因子: 3.7
作者: [Arai Y, Totoki Y, Takahashi H, Nakamura H, Hama N, Kohno T, Tsuta K, Yoshida A, Asamura H, Mutoh M, Hosoda F, Tsuda H, Shibata T]
通讯作者: Shibata T
Comparison of genetic alterations in primary breast cancer and its metastatic tumor
原发性乳腺癌与其转移瘤的基因改变比较
DOI: --
发表时间: 2011
期刊:
影响因子: --
作者: [Hosoda F, Totoki Y, et al]
通讯作者: et al
Genetic variations in primary breast cancer and its metastatic tumor.
原发性乳腺癌及其转移性肿瘤的遗传变异。
DOI: --
发表时间: 2012
期刊:
影响因子: --
作者: [Hosoda F, et al.]
通讯作者: et al.
DOI: 10.1038/onc.2010.217
发表时间: 2010-08-01
期刊: ONCOGENE
影响因子: 8
作者: [Shibata, T., Kokubu, A., Hirohashi, S.]
通讯作者: Hirohashi, S.
共 9 条
    海外基金